Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Blocking certain proteins on immune cells may help treat alopecia areata.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Alopecia Areata often runs in families and is linked to other autoimmune conditions.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

miR-155 levels in blood could help identify alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Atopic dermatitis increases the risk of some autoimmune diseases.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.